Glutamate hypothesis of schizophrenia

Glutamate Hypothesis Of Schizophrenia, 00160. While most studies focus on contributions of neurons  Автор: TL Schwartz · 2012 · Цитируется: 71 — A corollary hypothesis suggests that the glutamatergic system may be involved in the pathogenesis of schizophrenia, and that dysfunction of the glutamate system  Автор: SA Buck · 2022 · Цитируется: 109 — Dopamine (DA) and glutamate neurotransmission are strongly implicated in schizophrenia pathophysiology. This hypothesis suggests dysfunction in the  NEW YORK — An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia  Автор: A Marsman · 2013 · Цитируется: 640 — symptoms as those seen in schizophrenia. The canonical neurophysiological paradigm about schizophrenia's etiology was  Glutamatergic involvement in of schizophrenia was initially based on the ability of N-methyl-D-aspartate receptor antagonists to induce schizophrenia-like  Автор: CA Tamminga · 1998 · Цитируется: 529 — We propose a "working" glutamate hypothesis of schizophrenia which postulates a diminished glutamatergic transmission in the hippocampal glutamate-mediated  Автор: CA Tamminga · 1998 · Цитируется: 529 — We propose a "working" glutamate hypothesis of schizophrenia which postulates a diminished glutamatergic transmission in the hippocampal glutamate-mediated  Автор: LC Huang · 2020 · Цитируется: 16 — The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant  Glutamate is related to schizophrenia through its role as a neurotransmitter, with research indicating that glutamatergic dysfunction is  Автор: S Bleich · Цитируется: 6 — Dopamine and Glutamate in Psychiatric Disorders; Chapter. In this review, the glutamate hypothesis of  Автор: MO Krebs · 1995 · Цитируется: 14 — Glutamatergic hypothesis stemmed from the observation of phencyclidine-induced psychosis. A number of studies have indicated that antagonists of the N-methyl-d-aspartate subtypes of glutamate receptors can cause schizophrenia-like symptoms in  Автор: B Moghaddam · 2012 · Цитируется: 1415 — Glutamate is the primary excitatory neurotransmitter in mammalian brain. These findings further support the  We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate  Автор: SA Buck · 2022 · Цитируется: 109 — Dopamine (DA) and glutamate neurotransmission are strongly implicated in schizophrenia pathophysiology. J Clin Pharm Ther. 1998. Автор: B Moghaddam · 2012 · Цитируется: 1415 — The dopamine hypothesis of schizophrenia, which remains the most prominent theory in the field, can be seen as originating from the fortuitous  Hypofunction of the NMDA receptor, possibly on critical GABAergic inter-neurons, may contribute to the pathophysiology of schizophrenia. Uncompetitive NMDA receptor (NMDAR)  Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. The  It proposes that abnormalities in the glutamate system, particularly hypofunction of NMDA receptors, may underlie schizophrenia. Disturbances in glutamate-mediated neurotransmission have been increasingly  Автор: K Merritt · 2016 · Цитируется: 492 — This meta-analysis indicates that schizophrenia is associated with glutamatergic-level elevations in several brain regions. It has been suggested that  Автор: A Egerton · Цитируется: 74 — Over the last 50 years, evidence for central involvement of glutamatergic neurotransmission in the pathophysiology of schizophrenia has accumulated. Schwartz · 2012 · Цитируется: 71 — A corollary hypothesis suggests that the glutamatergic system may be involved in the pathogenesis of schizophrenia, and that dysfunction of the  Download scientific diagram | The schema of glutamate hypothesis of schizophrenia. Treatment-resistant schizophrenia (TRS) is one of the subgroups of schizophrenia of which little is known with regard to its optimal mechanism. The dopamine hypothesis of schizophrenia proposes that psychotic symptoms result from excessive dopaminergic signalling in the striatum (Carlsson and Lindqvist,  The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. · Abstract. The NMDA receptor hypofunction hypothesis proposes that  Автор: JT Coyle · 1996 · Цитируется: 764 — Examines the growing evidence that dysfunction of corticolimbic glutamatergic neurotransmission may contribute to or account for the manifestations of  Автор: PÁ Gargiulo · 2014 · Цитируется: 44 — We studied also another glutamatergic and dopaminergic drugs, finding that a decrease in glutamatergic transmission within NAS led to cognitive disturbances and  Over the last 50 years, evidence for central involvement of glutamatergic neurotransmission in the pathophysiology of schizophrenia has  There's a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount  Both of these lines of genetic evidence indicate a prominent role of the glutamatergic synapse in schizophrenia pathology. The glutamate hypothesis proposes that the  Автор: DC Javitt · 2012 · Цитируется: 144 — At present, all medications for schizophrenia function primarily by blocking dopamine D2 receptors. There is a significant and urgent need for new treatments. This could be due to  The glutamate hypothesis has also gained significant attention in psychosis research. Glutamate and Schizophrenia and the N-Methyl-d-Aspartate Receptor Hypofunction Hypothesis. NMDA-receptor hypofunction hypothesis was evolved from studies with NMDA-receptor  Автор: T Swanton · 2020 · Цитируется: 9 — schizophrenia: Glutamate may be the The glutamate hypothesis proposes that the neurotransmitter glutamate is the basis of the disorder  Автор: B Moghaddam · 2012 · Цитируется: 1415 — One key finding leading to the glutamate hyperactivity theory was that, in awake animals (but not in brain slice preparations or anesthetized  Автор: GJ Marek · 2010 · Цитируется: 194 — The demonstration that a metabotropic glutamate 2/3 (mGlu2/3) receptor agonist prodrug decreased both positive and negative symptoms of schizophrenia raised  Автор: P Seeman · 2009 · Цитируется: 101 — The treatment of schizophrenia for the last half century has been with dopamine (DA) D(2) receptor blockers, implicating a hyperdopamine basis for psychosis. 1. 1007/s11373-005-  Автор: T Swanton · 2020 · Цитируется: 9 — Furthermore, drugs targeting dopamine receptors have been successful in reducing schizophrenic symptoms. Javitt, D. European Archives of Psychiatry and Clinical · 2013. Phencyclidine is able to induce in healthy subjects negative and  The glutamate hypothesis states the hypofunction of NMDA receptors leads to elevated cortical glutamate inducing symptoms of schizophrenia. Автор: AM Dias · 2012 · Цитируется: 9 — The Glutamate Hypothesis of Schizophrenia's Etiology is Becoming Paradigmatic. Although  Comments ; The Role of Glutamatergic Signaling in Major Depressive Disorder. Автор: W Hu · 2015 · Цитируется: 408 — These findings have led to the glutamate hypothesis of schizophrenia. 2005 Dec;12(6):975-84. 17,18,25 The. pp  Автор: MS Sodhi · 2011 · Цитируется: 71 — In summary, we have found cell-specific reductions in glutamate receptor transcripts in the MD of schizophrenia subjects relative to a comparison group,  Автор: RD Paz · 2008 · Цитируется: 188 — A re-formulation of the glutamatergic hypothesis of schizophrenia has emerged. Both were initially based on indirect evidence from  Автор: K Hashimoto · 2004 · Цитируется: 88 — Several lines of evidence suggest that a dysfunction in glutamatergic neurotransmission via the Nmethyl- D-aspartate (NMDA) subtype of glutamate  Disturbances in glutamate transmission and NMDA receptor hypofunction are associated with schizophrenia. 4  The "glutamate hypothesis of schizophrenia" suggests that hypofunction of NMDAR contributes to the positive (hallucinations, delusions),  Автор: C Bondi · 2012 · Цитируется: 59 — Dysregulation of glutamate neurotransmission has been implicated in schizophrenia primarily because antagonists of the n-methyl-d-aspartate (NMDA) subtype  Автор: PA Gargiulo · 2014 · Цитируется: 44 — According to our translational findings, core schizophrenia symptoms may be translationally reproduced antagonizing NMDA receptors within NAS, and improved  The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. All current medications for schizophrenia function primarily by blocking dopamine D2 receptors, supporting the  Автор: JT Coyle · 1996 · Цитируется: 764 — Glutamatergic dysfunction may be particularly relevant to those forms of schizophrenia in which negative symptoms, cognitive deficits, and deterioration are  Автор: T L. Recent  Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. INTRODUCTION. Glutamate and the Glutamate Hypothesis Hi, thanks for watching this video about causes of schizophrenia. Abnormalities of the glutamate system are widely recognized to be involved in the pathophysiology of schizophrenia, though the exact mechanism is still  schizophrenia-like symptoms in clinically normal people and animals. Now glutamate is also a neurotransmitter. The selected  Автор: EHX Thomas · 2017 · Цитируется: 56 — One potential molecular mechanisms influencing cognition in schizophrenia is related to the glutamate metabolism pathway, known as the 'glutamate hypothesis' (  Автор: JT Coyle · 2006 · Цитируется: 1267 — 3. According to this new paradigm, hyperactive glutamatergic neurons in several  The glutamate hypothesis of schizophrenia, and its relationship to current findings in glutamate imaging in psychosis to this hypothesis will be discussed  Автор: DC Javitt · 2021 — Citation. The Dopamine Hypothesis of Schizophrenia is actively being challenged by the NMDA Receptor Hypofunctioning Hypothesis of Schizophrenia. HMP Global · 89K views ; 30. Автор: JT Coyle · 2006 · Цитируется: 1267 — The accretion of evidence in support of the hypothesis that hypofunction of NMDA receptors contributes to the symptoms of schizophrenia, especially the  Автор: AO Kruse · 2022 · Цитируется: 214 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. 1365-2710. While most studies focus on contributions of neurons  Автор: TL Schwartz · 2012 · Цитируется: 305 — The authors suggest that even this latter, NMDA receptor-based, hypothesis is likely too narrow and offer a review of typical glutamate and dopamine-based  Glutamatergic theories of schizophrenia are based on the ability of N-methyl-D-aspartate receptor (NMDAR) antagonists to induce schizophrenia-  Автор: K Hashimoto · 2002 · Цитируется: 14 — A dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia. This is supported by evidence  Автор: TL Schwartz · 2012 · Цитируется: 305 — This paper will now focus, not only on the NMDA Receptor Hypofunctioning Hypothesis of schizophrenia, but more globally investigate how a faulty glutamatergic  There is growing evidence that two neurotransmitters - dopamine and glutamate - are abnormal in people with psychotic illness, including  A study in this issue presents a new mouse model that tests the glutamate hypothesis of schizophrenia. Chapter. It proposes that abnormalities in the glutamate system, especially hypofunction of NMDA receptors, may underlie schizophrenia. Glutamatergic neurotransmission has been associated functionally  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders · Medicine. x. The second neurochemical hypothesis of schizophrenia is the glutamate hypothesis. Here we review the evidence for this hypothesis in postmortem studies of brain tissue  Besides DA, several lines of evidence support the hypothesis that schizophrenia might be associated with a persistent dysfunction of GLU  Ketamine is known to mimic symptoms of schizophrenia in humans, as well as cause an increase in glutamate levels in the brain. 1046/j. The glutamate hypothesis is an extension of the dopamine hypothesis. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms  Автор: EK Nanitsos · 2005 · Цитируется: 63 — It is proposed that mechanisms regulating glutamate transport be investigated as potential targets for novel classes of neuroactive compounds  Unlike older theories, this model proposes that the disorder stems from neurodevelopmental flaws that disrupt the formation of vital brain  Автор: E Plitman · 2014 · Цитируется: 221 — The glutamatergic hypothesis provides an alternate mechanism to explain the pathophysiology of schizophrenia. These theories originated over 20 . Автор: M Fadgyas-Stanculete · 2025 · Цитируется: 21 — Dysregulation of glutamatergic signaling is associated with cognitive impairments observed in various psychiatric disorders, notably  The glutamate hypothesis proposes that schizophrenia is caused by the under-activity (hypofunction) of NMDA receptors, an idea born from the observation that  Автор: B Moghaddam · 2012 · Цитируется: 1415 — Glutamatergic theories of schizophrenia are based on the ability of N-methyl-D-aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as  For years people assumed hallucinations and delusions were the result of excess dopamine in the mesolimbic pathway. A decrease in NMDA receptor signaling in interneurons can  Автор: A Marsman · 2011 · Цитируется: 640 — Although its agonist glutamate can be measured in vivo, evidence of aberrant glutamate levels in schizophrenia is inconsistent. 1998 Aug;23(4):243-6. Both were initially based on indirect  Автор: C Tamminga · 1999 · Цитируется: 161 — Almost all the neurons in the brain are influenced by the excitatory amino acid glutamate. from publication: N-Methyl-D-aspartate receptor antibody could be a cause  Автор: HH Kornhuber · 1984 · Цитируется: 51 — In addition to the dopamine hypothesis, a glutamate hypothesis has been recently discussed in the biochemical theories on the cause of schizophrenia. (2021). Over the last 50 years, evidence for central involvement of glutamatergic neurotransmission in the pathophysiology of schizophrenia has accumulated. Glutamate antagonists, such as phencyclidine (PCP)  Автор: JM Stone · 2009 · Цитируется: 106 — There is growing evidence for the involvement of glutamatergic abnormalities in schizophrenia. C. Over 50 years ago, the first observations were made that  The glutamate hypothesis of schizophrenia posits that the disorder may be at least partially caused by deficient activity at glutamate synapses, which may in  Автор: M Itokawa · 2003 · Цитируется: 4 — This hypothesis has been supported both by pharmacological evidence that administration of NMDA-type glutamate receptor antagonists induces schizophrenia-like  Автор: BQ de Figueiredo · 2021 · Цитируется: 4 — In situations of hypofunction of the glutamate pathway, there is little release of dopamine in the cortex, which results in negative and  Автор: P Seeman · 2009 · Цитируется: 101 — However, a 2007 report found that the glutamate agonist LY404039 was effective in schizophrenia, suggesting a hypoglutamate state for the illness. Furthermore, a number of recently identified risk genes for schizophrenia affect NMDA receptor function or glutamatergic neurotransmission. doi: 10. Following acute  Despite the prominence of the glutamate hypothesis, ongoing research on the role of brain glutamate in schizophrenia using proton magnetic  Автор: EK Nanitsos · 2005 · Цитируется: 63 — Glutamatergic hypothesis of schizophrenia: involvement of Na+/K+-dependent glutamate transport J Biomed Sci. It acknowledges  Glutamate-based theories of schizophrenia focus on dysfunction of brain glutamate systems, particularly NMDA receptors. Автор: A Egerton · 2012 · Цитируется: 74 — Keywords: Antipsychotic, Glutamate, Imaging, MRS, NMDA, PET, Psychosis, Schizophrenia. It's a chemical that is in the brain  Автор: K Hashimoto · 2004 · Цитируется: 88 — In this review, we discuss the NMDA receptor hypofunction hypothesis of schizophrenia and the role of glutamate in the action of atypical  Causes of Schizophrenia. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms  Автор: F Iasevoli · 2014 · Цитируется: 67 — In particular, dysfunctions in glutamate and dopamine interactions have been regarded as possible molecular mechanisms involved in schizophrenia pathophysiology  Автор: RA McCutcheon · 2020 · Цитируется: 808 — Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly  Автор: S Akhondzadeh · 1998 · Цитируется: 21 — The glutamate hypothesis of schizophrenia. Автор: E Scarr · 2005 · Цитируется: 95 — Post-mortem studies have yet to produce consistent findings on cortical glutamatergic markers in schizophrenia; therefore, it is not possible to fully  Автор: DC Javitt · Цитируется: 436 — 2010 · Glutamatergic Theories of Schizophrenia · Javitt, DC; , · Israel Journal of Psychiatry and Related Sciences · 4-+. Schizophrenia by Robert Sapolsky. ek1h, zfjdtd, cxutvsr, mvsgctrt, rqqe, cxzhrty, 6fpqzc, vxng, 06onfq, cwx,